CCA cells express H1 and H2 receptors, and administration of antagonists for H1 receptor (mepyramine) or H2 receptor (ranitidine) decreased Mz-ChA-1 tumor size by decreasing expression levels of HDC and VEGF-A in the xenograft nude mouse model in vivo [105]. Here, VEGFA is linked to cholangiocarcinoma.